Forget hydroxychloroquine or Ivermectin. But there is one existing medicine that shows signs of benefiting COVID-19 patients: fluvoxamine.
. But there’s promising news that another generic medicine has shown the ability to moderate the course of the disease.
Several clinical trials, including a large trial with 1,500 test subjects, indicate that the drug may help COVID-19 patients in the early stages of the disease stay out of the hospital and avoid long hours under the eyes of emergency room physicians. That may be because it won’t work as an alternative to vaccines. Unlike the others, however, fluvoxamine has a plausible mechanism of action that may explain how it works for COVID-19 patients and why it should be a candidate for inclusion in the slowly expanding arsenal of treatments.
“We already know about its safety, since it has been on the market for more than 25 years,” Lenze says. “I am hoping that the medical and scientific community embraces this as a proven treatment for early COVID-19 and it starts to be utilized.”a “60 Minutes” report in March
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Parents in despair over kids going remote again because of COVID-19More and more districts are going back to a virtual learning model as cases continue to soar.
Consulte Mais informação »
Asia shares ease on worries over China crackdown, COVID-19 spikeAsian shares stumbled on Tuesday, rattled by concerns over China's regulations for its once-freewheeling internet sector and the worldwide spike in COVID-19 infections driven by the Delta variant.
Consulte Mais informação »
Los anticuerpos por infección COVID-19 se mantienen más de un año, según un estudioLa mayoría de quienes han pasado la COVID-19, independientemente de la gravedad, tienen anticuerpos protectores hasta un año después de la infección, según un estudio del IrsiCaixa en colaboración con el Centro de Investigación en Sanidad Animal (CReSA) y el Barcelona Supercomputing Center (BSC).
Consulte Mais informação »
COVID-19 live updates: Biden admin expected to recommend booster shots for vaccinated AmericansBangladesh has launched a COVID-19 vaccination program for Rohingya refugees housed in one of the world's largest and most densely populated camps in Cox's Bazar, according to the World Health Organization.
Consulte Mais informação »
Single Covid-19 Case In Auckland Triggers Nationwide Lockdown In New ZealandNew Zealand, which has successfully pursued a ‘zero-Covid’ strategy, reported its first case of community transmission in six months.
Consulte Mais informação »
Unvaccinated couple die of COVID-19 hours apart, leaving behind 2 teensMartin and Trina Daniel, married for over 20 years, both died of COVID-19 within hours of each other, leaving behind two teenage children facing an unimaginable loss.
Consulte Mais informação »